Identification of 4-deoxythreonic acid present in human urine using HPLC and NMR techniques.

The 1H NMR spectrum of urine exhibits a large number of detectable and quantifiable metabolites and hence urine metabolite profiling is potentially useful for the study of systems biology and the discovery of biomarkers for drug development or clinical applications. While a number of metabolites (50-100) are readily detectable in urine by NMR, a much larger number is potentially available if lower concentration species can be detected unambiguously. Lower concentration metabolites are thought to be more specific to certain disease states and thus it is important to detect these metabolites with certainty. We report the identification of 4-deoxythreonic acid, a relatively low concentration endogenous metabolite that has not been previously identified in the 1H NMR spectrum of human urine. The use of HPLC and NMR spectroscopy facilitated the unequivocal and non-invasive identification of the molecule in urine which is complicated by extensive peak overlap and multiple, similar resonances from other metabolites such as 3-hydroxybutanoic acid. High-resolution detection and good sensitivity were achieved by the combination of multiple chromatographic fraction collection, sample pre-concentration, and the use of a cryogenically cooled NMR probe.

[1]  S. Markey,et al.  Gas-chromatographic/mass-spectrometric identification and quantitation of tetronic and deoxytetronic acids in urine from normal adults and neonates. , 1975, Clinical chemistry.

[2]  D. Raftery,et al.  Metabolomics-based methods for early disease diagnostics , 2008, Expert review of molecular diagnostics.

[3]  Daniel Raftery,et al.  Use of selective TOCSY NMR experiments for quantifying minor components in complex mixtures: application to the metabonomics of amino acids in honey. , 2005, Analytical chemistry.

[4]  Manfred Spraul,et al.  Metabolite profiling of human amniotic fluid by hyphenated nuclear magnetic resonance spectroscopy. , 2008, Analytical chemistry.

[5]  Erik J. Saude,et al.  Variation of metabolites in normal human urine , 2007, Metabolomics.

[6]  Daniel Raftery,et al.  Use of EDTA to minimize ionic strength dependent frequency shifts in the 1H NMR spectra of urine , 2008, Metabolomics.

[7]  Oliver Fiehn,et al.  Plant Metabolomics , 2002, The Plant Cell Online.

[8]  J. Lindon,et al.  'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. , 1999, Xenobiotica; the fate of foreign compounds in biological systems.

[9]  T. Hoye,et al.  Mosher ester analysis for the determination of absolute configuration of stereogenic (chiral) carbinol carbons , 2007, Nature Protocols.

[10]  Oliver Fiehn,et al.  A comprehensive urinary metabolomic approach for identifying kidney cancerr. , 2007, Analytical biochemistry.

[11]  N. Serkova,et al.  Pattern recognition and biomarker validation using quantitative 1H-NMR-based metabolomics , 2006, Expert review of molecular diagnostics.

[12]  J P Shockcor,et al.  Combined HPLC, NMR spectroscopy, and ion-trap mass spectrometry with application to the detection and characterization of xenobiotic and endogenous metabolites in human urine. , 1996, Analytical chemistry.

[13]  D. Kassel,et al.  Urinary metabolites of L-threonine in type 1 diabetes determined by combined gas chromatography/chemical ionization mass spectrometry. , 1986, Biomedical & environmental mass spectrometry.

[14]  Daniel Raftery,et al.  Signal enhancement in HPLC/microcoil NMR using automated column trapping. , 2006, Analytical chemistry.

[15]  Karen Willcox,et al.  Kinetics and kinematics for translational motions in microgravity during parabolic flight. , 2009, Aviation, space, and environmental medicine.

[16]  M. Spraul,et al.  Application of the one-dimensional TOCSY pulse sequence in 750 MHz 1H-NMR spectroscopy for assignment of endogenous metabolite resonances in biofluids. , 1994, Journal of pharmaceutical and biomedical analysis.

[17]  S. Hansen,et al.  Human urine as test material in 1H NMR-based metabonomics: recommendations for sample preparation and storage. , 2007, Analytical chemistry.

[18]  Daniel Raftery,et al.  Use of semiselective TOCSY and the pearson correlation for the metabonomic analysis of biofluid mixtures: application to urine. , 2005, Analytical chemistry.

[19]  I. Wilson,et al.  NMR and HPLC-NMR spectroscopic studies of futile deacetylation in paracetamol metabolites in rat and man. , 1997, Journal of pharmaceutical and biomedical analysis.

[20]  Daniel Raftery,et al.  Ibuprofen metabolite profiling using a combination of SPE/column-trapping and HPLC-micro-coil NMR. , 2008, Journal of pharmaceutical and biomedical analysis.

[21]  Ian D. Wilson,et al.  HIGH RESOLUTION PROTON MAGNETIC RESONANCE SPECTROSCOPY OF BIOLOGICAL FLUIDS , 1989 .

[22]  Mark R Viant,et al.  NMR-based metabolomics: a powerful approach for characterizing the effects of environmental stressors on organism health. , 2003, Environmental science & technology.

[23]  Andrew N. Lane,et al.  Structure-based profiling of metabolites and isotopomers by NMR , 2008 .

[24]  C. Barbas,et al.  Correlative and quantitative 1H NMR-based metabolomics reveals specific metabolic pathway disturbances in diabetic rats. , 2008, Analytical biochemistry.

[25]  F. Collins,et al.  Principles of Biochemistry , 1937, The Indian Medical Gazette.

[26]  M. Arnal,et al.  Assessment of threonine metabolism in vivo by gas chromatography/mass spectrometry and stable isotope infusion. , 1991, Analytical biochemistry.

[27]  J. Lindon,et al.  Spectroscopic and statistical techniques for information recovery in metabonomics and metabolomics. , 2008, Annual review of analytical chemistry.

[28]  Jan van der Greef,et al.  Symbiosis of chemometrics and metabolomics: past, present, and future , 2005 .

[29]  Y. Dragan,et al.  Evaluation of NMR spectral data of urine in conjunction with measured clinical chemistry and histopathology parameters to assess the effects of liver and kidney toxicants , 2007, Metabolomics.

[30]  John C. Lindon,et al.  Pattern recognition methods and applications in biomedical magnetic resonance , 2001 .

[31]  Ying Zhang,et al.  HMDB: the Human Metabolome Database , 2007, Nucleic Acids Res..

[32]  I. Wilson,et al.  The application of microbore UPLC/oa-TOF-MS and 1H NMR spectroscopy to the metabonomic analysis of rat urine following the intravenous administration of pravastatin. , 2007, Journal of pharmaceutical and biomedical analysis.

[33]  Daniel Raftery,et al.  Principal component analysis of urine metabolites detected by NMR and DESI–MS in patients with inborn errors of metabolism , 2007, Analytical and bioanalytical chemistry.

[34]  E Holmes,et al.  Chemometric models for toxicity classification based on NMR spectra of biofluids. , 2000, Chemical research in toxicology.